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Abstract
Asthma is a common chronic inflammatory disease. Pathogenic mechanism 
underlying asthma is complex. The inflammatory response of asthma includes 
lymphocytes (T, B cells), ILC2, eosinophils and other types of immune and inflam-
matory cells. T CD4+ T helper 2 cells (Th2 cells) are thought to play a central role 
in regulating the phenotype of allergic asthma. Asthma is often closely associated 
with Th1/Th2 cell imbalance. Non-coding RNAs (ncRNAs) are non-protein coding 
RNA molecules in the transcriptome, mainly including microRNAs (miRNAs), 
long non-coding RNAs and circRNAs, etc., which are widely found in eukaryotic 
transcriptome and participate in the regulation of a variety of biological processes. 
ncRNAs are considered to function as modulators of the immune system. Their 
biological changes represent an important mechanism for the development of 
immune-mediated diseases. This chapter mainly discusses the epigenetic regulation 
of Th2 cells and their cytokines in asthma by non-coding RNAs. It helps us to better 
understand the pathogenesis of asthma and find potential asthma biomarkers.
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1. Introduction
Asthma is a chronic airway inflammatory disease, associated with variable expi-
ratory airflow limitation, clinically manifested as recurrent wheezing, shortness of 
breath, chest tightness, cough and other symptoms [1]. It has affected more than 
300 million people worldwide and has become a major public health concern [2].
Non-coding RNAs (ncRNAs) are a class of non-coding RNA molecules widely 
found in eukaryotes and involved in a variety of biological regulatory processes. 
They have been extensively studied in human diseases [3–5]. NcRNAs mainly 
includes microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs 
(circRNAs), etc.
The pathogenesis of asthma remains extremely complicated and the detailed 
mechanisms are not clarified. The most common phenotype is eosinophilic inflam-
mation associated with Th2 response and concomitant atopic diseases. Asthma is 
often closely associated with Th1/Th2 cell imbalance. Th2 cells secrete Th2 cyto-
kines, including interleukin-IL-4, IL-5, and IL-13, which amplify type 2 inflam-
mation, while Th1 cells secrete Th1 cytokines [interferon IFN-γ, IL-2, lymphoid 
(LT)-α, and tumor necrosis factor TNF-α, which limit type 2 inflammation [6, 7]. 
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The CD4+ T cells are major effector cells driving asthma-related inflammation 
and the skewing of T cells into Th2 cells can lead to imbalance of Th1-type and 
Th2-type cytokines, which promotes the onset and progression of asthma. [8, 9]. 
Understanding the factors contributing to Th2 in asthma will provide important 
insights into the underlying pathogenesis of the disease. The skewing of T cells into 
Th2 cells causes an imbalance of Th1-type and Th2-type cytokines, which promotes 
the onset and progression of asthma. A number of studies have shown that ncRNAs 
may play an important role in Th2 cell-mediated inflammation in asthma. This 
chapter mainly discusses the epigenetic regulation of Th2 response in asthma by 
non-coding RNAs, in order to better understand the disease pathogenesis and find 
potential asthma biomarkers.
2. Regulation of microRNAs on Th2 in asthma
MicroRNAs are a group of small nonprotein-coding RNAs that are 18–25 
nucleotides in length. They act as transcriptional regulators involved in many 
complex human disorders and in biological processes including cell proliferation 
and apoptosis [10–12]. MiRNA expression profiles have also been described in some 
allergic conditions and asthma [13]. Previous studies have suggested that miRNAs 
are involved in the development of allergic diseases by affecting Th1/Th2 polariza-
tion, promoting chronic inflammation and tissue remodeling of epithelial cells, and 
activating innate immune cells [13]. Th2-mediated inflammation is the core of the 
pathogenesis of allergic asthma. Th2-dominated T lymphocytes regulate allergic 
diseases by secreting a variety of proinflammatory cytokines. Recent studies have 
shown that most of the miRNAs involved increase Th2 cytokine secretion, reduce 
Th1 cytokine secretion, promote T cell differentiation to Th2, or play a role in the 
proliferation and hypertrophy of bronchial smooth muscle cells [14–16]. There is no 
doubt that miRNA plays a role in the regulation of asthma inflammation. MiRNAs 
may regulate Th2 in asthma by affecting Th1/Th2 balance, secretion of Th2 cyto-
kines and related signaling pathways.
2.1 Regulation of Th2 cytokines by miRNAs
Th2-mediated inflammation is the core of the pathogenesis of allergic asthma. 
Typical cytokines involved in the Th2 response are IL-4, IL-5, and IL-13. Pua et al. 
[15] studied the miRNA related to Th2 cell differentiation and cytokine produc-
tion by combining experimental and bioinformatics methods, and found that both 
miR-24 and miR-27 inhibited the production of IL-4 in T cells in vitro. Inhibition 
of the function of miR-145 suppresses house dust mites (HDM)-induced mucus 
hypersecretion in airway epithelial cells, eosinophilic inflammation, th2 cytokine 
production, and airway hyperresponsiveness as effectively as dexamethasone 
treatment. This study shows that miR-145 plays a key role in the occurrence and 
pathogenesis of allergic airway disease caused by house dust mites by inducing the 
release of IL-5 and IL-13 from Th2 cells [14]. Panganiban et al. found a variety of 
differentially expressed miRNAs in the serum of patients with asthma, and pre-
dicted that these miRNAs could regulate IL-5 and other TH2 mediators [17]. It was 
further confirmed that IL-5 was regulated by miRNA, and miR-1248 was identified 
as a positive regulator of IL-5 expression [17]. IL-10 levels are reduced in asthmatic 
patients, and the relative deficiency of IL-10 allows continued production of 
allergenic cytokines, such as IL-4 and IL-5, and other pro-inflammatory cytokines, 
including IL-1, TNF-α, and IL-6 [18]. Inhibition of miR-106a promotes IL-10 secre-
tion and helps alleviate asthma symptoms by increasing Th2 response in a mouse 
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model of asthma [19]. Simpson et al. demonstrated that the miR-17 ∼ 92 cluster, 
and specifically miR-19a, promotes Th2 cytokine production by simultaneously 
targeting inhibitors of the NF-κB, JAK–STAT, and PI (3)K pathways. Their data also 
suggest that upregulation of miR-19a in asthma airway T cells may be an indicator 
and cause of increased IL-13 production and may contribute to type 2 inflammation 
in asthma [20]. In ovalbumin (OVA)-induced asthma mice, miR-146a significantly 
inhibited inflammatory cell infiltration in bronchoalveolar lavage fluid (BALF) 
and reduced levels of OVA-specific IgE and T-helper 2 cell type cytokines (IL-5 
and IL-13) [21]. MiR-146a may act as a novel therapeutic molecule to modulate the 
immune response of asthma. MiR-155 has been shown to be a key modulator of the 
immune system. MiR-155 may regulate Th2 inflammation by regulating Th2 cell 
differentiation and the secretion of IL-4, IL-5 and IL-13. These studies suggest that 
targeting miR-155 may be a novel therapeutic strategy for human diseases induced 
by the Th2 immune response, such as asthma [22, 23]. It has been found that let-7 
microRNAs inhibit IL-13 expression and thereby modulate Th 2 inflammation in an 
IL-13-dependent mouse model of allergic airway inflammation [24]. In ovalbumin 
(OVA) -induced asthma mice, intranasal administration of miR-410 significantly 
reduced the expression of IL-4 and IL-13 and effectively inhibited airway inflam-
mation in OVA-induced asthmatic mice. Therefore, targeting to increase the expres-
sion of miR-410 may be a promising approach for the treatment of allergic asthma 
[25]. In a mouse model of asthma induced by ovalbumin, the researchers tested 
the airway hyperresponsiveness, rt-pcr detection of miR - 135 a content in the lung 
tissue of mice, HE staining to evaluate the pathological changes of lung tissue and 
ELISA and immunohistochemical detection of bronchoalveolar lavage fluid (BALF) 
and lung tissue of the tumor necrosis factor (TNF) - alpha, interleukin (IL) - 6, 
IL - 5 and eosinophils chemokine expression. The results of this study showed that 
miR-135a decreased expression in asthmatic mice, and miR-135a reduced the levels 
of inflammatory cytokines TNF-α, IL-6, IL-5 and eosinophilic chemokines in the 
lung tissue of mice, thereby reducing airway inflammation. Further research in 
this study showed that miR-135a inhibited airway inflammation in asthmatic mice 
by regulating the JAK/STAT signaling pathway [26]. Previous studies in human, 
animal models, and cell culture have shown that the Th2 cytokine IL-13 is an 
important cause of airway epithelial abnormalities in asthma [27–29]. Kuperman 
et al. used miRNA microarray to analyze the bronchial epithelial cells of asthmatic 
patients and healthy control subjects, and found that the expression of miR-34/449 
family members was decreased in asthmatic patients. IL-13-induced reduction of 
miR-34/449 in bronchial epithelial cells may lead to changes in epithelial differen-
tiation common in asthma [30]. Zhang et al. investigated the role of miR-221-3p in 
airway eosinophilic inflammation in a mouse model of HDM-induced allergic air-
way inflammation, and showed that epithelial miR-221-3p expression was reduced 
in asthma. Airway overexpression of miR-221-3p induced the expression of IL-4, 
IL-5, and IL-13 mRNAs in the lungs of mice induced by HDM [31]. The expression 
of miR-26a, miR-146a, and miR-31 and cytokine levels of IL-5, IL-8, IL-12, and 
TNF-α were measured in lung tissue and bronchoalveolar lavage fluid of asthmatic 
mice and children with ovalbumin induced asthma. The results showed that 
miR-26a, miR-146a, and miR-31 were significantly elevated in asthma, and were 
involved in the progression of asthma by regulating the expression of inflammatory 
cytokines IL-5, IL-8, IL-12, and TNF-α [32]. The systems immunology approach 
(the Impact of Differential Expression Across Layers, a network-based algorithm 
to prioritize disease-relevant miRs based on the central role of their targets in the 
molecular interactome) was used to antagonize miRs (miR27b, miR206, miR106b, 
miR203, and miR23b) in vitro, which has significantly reduced cytokine production 
in Th2 cells. These results suggest that these miRNAs play an important role in the 
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Th2-driven immune response [33]. In conclusion, many miRNAs play an important 
role in asthma by regulating the secretion of Th2 cytokines. They may be new 
targets for the treatment of asthma in the future.
2.2 Regulation of Th1/Th2 balance by miRNAs
Qui et al. detected the levels of Th1- and Th2-related cytokines by ELISA, 
performed microRNA microarray assay and analyzed the differentiation marker 
gene of T helper cells by qRT-PCR. The results indicated that an imbalance of Th1/
Th2 cells was present in the asthmatic patients; Runx3 expression is decreased in 
asthmatic patients; overexpression of Runx3 could restore the Th1/Th2 balance; 
miR-371, miR-138, miR-544, miR-145, and miR-214 could directly bind to the 
3’-UTR of Runx3. All these findings suggest that these miRNAs may be involved in 
Th1/Th2 imbalance in asthma by regulating Runx3 [34]. One study used predictive 
algorithms dentified potential direct miR-21 targets among IL-13-regulated lung 
transcripts such as IL-12p35 mRNA that was decreased in IL-13 transgenic mice. 
MiR-21 was significantly elevated in ovalbumin-induced mice lungs, suggesting 
that miR-21 regulates Th1 to Th2 phenotypic transformation by decreasing the 
mouse IL-12p35 transcriptome [16]. Reduced levels of miR-29b were found in the 
lungs and spleens of OVA-induced asthmatic mice, and this miRNA indirectly 
affects the Th2 response by regulating the production of T-box transcription factors 
and IFN-γ in T helper cells [35]. Low expression of miR-29b in asthmatic lung can 
increase the production of IFN-γ and restore the balance of Th1/Th2 in asthmatic 
lung [36]. The researchers evaluated the relationship between miRNA levels in 
small extracellular vesicles (sEVs) from nasal washing and pulmonary function 
parameters in children with mild to moderate or severe asthma compared to healthy 
controls. The results showed that lower levels of miR-34a, miR-92b and miR-210 
in children with sEVs in this study were associated with pulmonary function and 
airway obstruction. Subsequent functional pathway analysis showed reduced levels 
of miR-92b, miR-210, and miR-34a in epithelial-derived sEVs in asthma, and these 
miRNAs regulate Th2 polarization and dendritic cell maturation [37].
2.3 miRNAs regulation of Th2 differentiation via signaling pathways
Inhibition of microRNA-126 (miR-126) has been shown to effectively inhibit 
Th2-driven airway inflammation, mucus hypersecretion, and airway hyperrespon-
siveness in a model of ovalbumin (OVA) -induced chronic asthma [38]. The block-
ing of miR-126 leads to the enhanced expression of POU domain 2 related factor 
1, which activates the transcription factor PU1, that changes the function of Th2 
cells by negatively regulating the expression of GATA3 [39]. In childhood asthma, 
miRNA-451a was found to inhibit Th2 cell differentiation by down-regulating proto-
oncogene 1 (ETS1). This study reveals that miRNA-451a-ETS1 axis dysfunction is 
a novel molecular mechanism that underlies the pathogenesis of childhood asthma 
[40]. A study has shown that miR-1165-3p targets IL-13 and PPM1A to control Th2 
differentiation and pulmonary inflammation in asthma. miR-1165-3p inhibits the 
Th2 response of allergy through the STAT and AKT signaling pathways by targeted 
inhibition of protein phosphatase, Mg 2+/Mn 2+ − dependent 1A (PPM1A), thus 
proving that miR-1165-3p and PPM1A may be effective targets for the prevention 
and treatment of allergic asthma and related diseases [41]. The miR-29c/B7-H3 axis 
plays an important role in asthmatic children by regulating Th2/Th17 cell differen-
tiation, and may provide a new target for asthma treatment [42]. The role of Th2-
mediated microRNAs in asthma are summarized in the Table 1 (Figure 1).
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3. lncRNA regulate Th2 response in asthma
LncRNA refers to a class of RNA molecules with a length greater than 200 
nucleotides which do not have the function of coding RNAs. LncRNAs are mainly 
involved in gene expression regulation at the transcription, post-transcription, 
translation and epigenetic levels, and are widely involved in various life processes 
such as cell proliferation, differentiation, apoptosis, migration, aging and metabo-



















miR-29c Up-regulated miR-29c / 
B7-H3





























Regulation of Th2 in asthma by miRNAs.
Figure 1. 
Regulation of Th2 in asthma by miRNAs. Th1 and Th2 are in equilibrium. miR-34a, miR-92b and miR-210 
regulate Th2 polarization. MiRNAs such as miR-371, miR-138, miR-544 and miR-145 affect Th1/Th2 balance 
of asthma by regulating Runx3. MiR-21 regulates Th1 and Th2 balance by regulating IL-12p35 transcripts. 
As shown in the figure, miR-24, miR-27, miR-410, let-7a, miR-145, miR-146a, miR-1248 and other miRNAs 
regulate the secretion of Th2 cytokines, such as IL-4, IL-5 and IL-13, through up-regulation or down-regulation 
in asthma, and affect the occurrence and development of asthma.
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suggesting that these transcripts play important roles in T cell development and 
differentiation [47]. Studies have found that some lncRNAs play important roles in 
the pathogenesis of asthma by regulating Th1/Th2 balance and Th2 inflammatory 
response [3, 48]. Understanding how lncRNAs alter gene expression to promote 
Th2 skewing may provide new insights into mechanisms and therapeutic targets 
for asthma.
3.1 Regulation of Th1/Th2 balance by lncRNAs
The gene encoding lncRNA MALTA1, a highly conserved nuclear lncRNA, is 
located on chromosome 11 (11q13.1). MALTA1 is highly expressed in most cells 
[49]. Liang et al. [50] conducted a cohort study of 772 asthmatic patients and 441 
healthy controls, and found that the expression of MALAT1 was up-regulated and 
the expression of miR-155 was down-regulated in the blood of asthmatic patients. 
MALAT1 expression was inversely associated with impaired lung function and the 
Th1 / Th2 ratio, suggesting that its role was to impairs lung function by promoting 
the Th2 response. That is, the up-regulated expression of MALAT1 can induce the 
production of Th2 cytokines and inhibit the release of Th1 cytokines. Further study 
of the experiment showed that MALAT1 sponging miR-155 could alter the Th1/Th2 
balance within CD4+ T cells through cytotoxic T-lymphocyte antigen 4 (CTLA-4) 
dependent mechanism. This study highlights the novel role of lncRNA MALTA1 in 
the development of Th2 in asthma. Wei et al. found that lncRNA PVT1 expression 
was increased in ozone-induced mouse asthma models, and the lncRNA PVT1-miR-
15a-5p axis promoted Th1/Th2 imbalance in CD4 + T cells by activating the PI3K-
Akt- signaling pathway [51].
3.2 lncRNA regulate Th2-type inflammation in asthma
Zhu et al. assessed expression of lncRNAs in peripheral blood samples of 
patients with eosinophilic asthma, neutrophilic asthma and healthy controls using 
RNA-sequencing. In this study, it was found that the expression of LNC_000127 
was increased in eosinophilic asthma, and knockdown of LNC_000127 (refer to 
this article for details) reduced the expression of CCR8, CRLF2, and CD40L (Th2 
inflammatory receptor). Targeting LNC_000127 may effectively reduce Th2 inflam-
mation in eosinophilic asthma [52]. It has been demonstrated that induced plu-
ripotent stem cells (iPSCs)-mesenchymal stem cells (MSCs) can effectively inhibit 
airway allergic inflammation in mice, and significantly reduce the expression levels 
of immunoglobulin (Ig) E and Th2 cytokines [53]. Further studies by Wang et al. 
[54] found that lncRNA MM9lincrnaexon12105 + and AK089315 were up-regulated 
in a model of ova-induced asthma. These two lncRNAs may be the main therapeutic 
targets of induced pluripotent stem cell mesenchymal stem cells (iPSC-MSCs) and 
may be involved in the regulation of Th2 type inflammation in asthma. This study 
provides an important basis for the study of the potential mechanisms of airway 
allergic inflammation and iPSC-MSC immune regulation, and these abnormal 
lncRNAs may become potential targets of allergic inflammation and iPSC-MSC 
mediated immune regulation. Wang et al. [55] conducted next-generation sequenc-
ing analysis of lncRNA and mRNAs on CD4 + T cells from ovalbumin-induced acute 
asthma mice and control mice, constructed co-expression networks of lncRNA and 
mRNAs, and found that lncRNA Fantom3_9230106C11 was decreased in Th2 cells. 
Further qRT-PCR verification showed that lncRNA Fantom3_9230106C11 could 
regulate the differentiation of Th2 cells. This study provides a platform to elucidate 
the role of lncRNA in Th2 differentiation and the pathogenesis of asthma. The role 
of Th2-mediated lncRNA in asthma are summarized in the Table 2 (Figure 2).
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4. circRNAs regulate Th2 response in asthma
CircRNAs compose a novel class of ncRNAs characterized by covalently closed-
loop structures [56]. CircRNAs typically act as molecular sponges to bind and 
inhibit the transcription or activity of microRNAs (miRNAs), thereby affecting 
downstream mRNA expression [57]. CircRNAs are involved in the pathogenesis of 
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lncRNA regulate Th2 response in asthma.
Figure 2. 
lncRNA regulate Th2 response in asthma. MALAT1 sponging miR-155 could alter the Th1/Th2 balance 
within CD4+ T cells through CTLA-4 dependent mechanism. lncRNA PVT1-miR-15a-5p axis promoted 
Th1/Th2 imbalance in CD4 + T cells by activating the PI3K-Akt- signaling pathway. LNC_000127, 
MM9lincrnaexon12105 + and AK089315 and lncRNA Fantom3_9230106C11 primarily regulate the Th2-type 
inflammation.
9
Epigenetic Regulation of Th2 Response in Asthma by Non-Coding RNAs
DOI: http://dx.doi.org/10.5772/intechopen.97328
various diseases [58]. The role of circRNA in asthma regulation is still in its infancy, 
and there are relatively few studies on the role of circRNA in the pathogenesis of 
asthma, especially Th2 inflammation in asthma.
Huang et al. [59] confirmed the expression of hsa_circ_0002594 in CD4 + T cells 
in asthmatic patients and healthy subjects by quantitative real-time PCR (qRT-
PCR) using circRNA microarray analysis (such as a student’s t test, nonparametric 
tests, Spearman’s rank-order correlation, Fisher’s exact test, and the generation of 
receiver operating characteristic curves). Their data suggest that hsa_circ_0002594 
is upregulated in CD4 + T cells of asthmatic patients, which may have potential 
value in the diagnosis and treatment of Th2-mediated allergic asthma. In a mouse 
model of HDM-induced asthma, the results revealed that the relative expression 
levels of circ_0000629 and circ_0000455 in the asthma group were significantly 
increased compared with those animals in the control group, whereas the expres-
sion levels of circ_0000454 and circ_0000723 were significantly decreased [60]. 
The circRNA-miRNA regulatory network indicated that two of the downregulated 
circRNAs (circ_0001454 and circ_0000723) targeted miR-146b and miR-214, and 
two of these upregulated circRNAs (circ_0000455 and circ_0000629) could target 
miR-29b and miR-15a [60]. The expression levels of inducible co-stimulator, a 
target gene of miR-29b, were also previously shown to be elevated in the lungs of 
asthmatic mice, and promoted Th2 cytokine production and eosinophilic inflam-
mation [61]. Furthermore, vascular endothelial growth factor, which is a target gene 
of mir-15a, was shown to be overexpressed in cases of Th2-mediated lung inflam-
mation, such as asthma, and induced an asthma-like phenotype [62]. By contrast, 
two of the downregulated circRNAs (circ_0001454 and circ_0000723) targeted 
miR-146b and miR-214, respectively, which were previously shown to be positively 
associated with asthma [34, 63]. Huang et al. found that hsa_circ_0005519 may 
induce IL-13 and IL-6 expression by regulating hsa-let-7a-5p in CD4+ T cells to 
affect asthma. And hsa_circ_0005519 may be a potential biomarker of asthma 
[64]. The role of Th2-mediated circRNAs in asthma are summarized in the Table 3 
(Figure 3).
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NcRNAs display a wide range of functions, and each ncRNA has its own charac-
teristics. This chapter mainly summarized the regulation of Th2 differentiation and 
immune response in asthma and experimental models of disease.
The role of miRNA in regulating Th2 cell-mediated inflammation in asthma 
is mainly reflected in several aspects: regulating Th1/Th2 balance, influencing 
cytokine secretion and regulating the activation state of T cells. The pathway of 
regulation can be that a single miRNA regulates one or more mRNAs, or multiple 
miRNAs of one or more gene clusters synergistically act on one or more mRNAs to 
exert biological effects. LncRNA plays a similar role to miRNA in regulating Th2 
cell-mediated inflammation in asthma, affecting its activation, transformation 
and cytokine secretion. Most of the existing studies only analyzed the expression 
profile of lncRNA and identified the differentially expressed lncRNA molecules, 
but did not conduct in-depth study on its precise molecular mechanism. CircRNAs 
may play important roles in Th2 cells differentiation and, thus, play regulatory roles 
in Th2 cell-mediated inflammation in asthma. They can act as competitive endog-
enous RNAs (ceRNAs, which can regulate each other by competitively binding 
common microRNA response elements) of miRNAs to exert their biological effects, 
but the specific mechanism needs to be further studied.
In conclusion, miRNA, lncRNA and circRNA play important roles in regula-
tion of Th2 cell function in asthma. However, the exact molecular mechanism of 
ncRNA in the regulation of TH2 cell function in asthma remains to be determined. 
Therefore, how to find out functional ncRNAs and elucidate their precise func-
tions present the difficulties and challenges in the study of ncRNAs in this field. 
In future, more and more ncRNAs involved in the pathogenesis of asthma will be 
discovered, and the role of ncRNAs in the inflammatory process mediated by Th2 
cells will be revealed. This will provide new details in the pathogenesis of asthma, 
and will help to develop new biomarkers and molecular targets for the diagnosis, 
classification, and treatment of asthma.
Figure 3. 
circRNAs regulate Th2 response in asthma. Hsa_circ_0005519 functions as an endogenous hsa-let-7a-5p 
sponge to regulate the hsa-let-7a-5p/IL-13/IL-6 pathway in CD4+ T cells. Two down-regulated circRNAs 
(circ_0001454 and circ_0000723) targeted miR-146b and miR-214, while two up-regulated circRNAs 
(circ_0000455 and circ_0000629) targeted miR-29b and miR-15a. These four circRNAs regulate TH2 cytokine 
production by targeting miRNA.
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